Compound 7P 10 mg – 60 capsules
research-grade
small-molecule capsules
in a sealed bottle. Studied in experimental models of GluN2B-selective NMDA receptor modulation, neuroprotection, mood regulation and cognitive function.
Research Use Only:
All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
High-purity research grade
Content
10 mg Compound 7P per capsule
Total count
60 capsules (total 600 mg per bottle)
Storage
Store at room temperature, protect from light, keep desiccated
Molecular formula
C19H16F3N3O
Molecular weight
~375.35 g/mol
IUPAC name
N-(4-Benzoylphenyl)-N′-[2-(trifluoromethyl)phenyl]urea
Research Overview
Compound 7P is a synthetic small molecule investigated as a selective, non-competitive negative allosteric modulator (NAM) of GluN2B-containing NMDA receptors. In experimental in vitro and in vivo models, it is used to explore how targeted NMDA receptor modulation influences excitotoxicity, synaptic plasticity, mood-related pathways and higher-order cognitive processes.
Primary Research Areas
-
GluN2B-selective NMDA receptor modulation:
used to study selective negative allosteric modulation of GluN2B-containing NMDA receptors within glutamatergic signaling pathways.
-
Neuroprotection and excitotoxicity models:
applied in experimental systems assessing neuronal survival, excitotoxic stress and downstream neuroprotective mechanisms.
-
Depression and mood-related research:
used in preclinical models probing NMDA receptor involvement in mood regulation and depression-like phenotypes.
-
Cognitive function and synaptic plasticity:
investigated in learning and memory paradigms to evaluate how GluN2B modulation affects synaptic plasticity and cognitive performance in laboratory settings.
-
Glutamate neurotransmission mechanisms:
supports studies dissecting glutamate receptor pharmacolo
